Zoetis Inc

ZTS remains in a Stage 4 downtrend and has consolidated in a narrow range below declining EMAs and key SMAs. Medium-term bias is bearish given lack of accumulation and persistent lower highs, while short-term charts show price rejection near the 9/20 EMAs. Selling into resistance around the upper end of the $7676 range aligns with the current structural and tactical context.

• ↑Q2 revenue flat at $2.5B, livestock sales surged 23%.
• ↑Adjusted net income $781M (adj. EPS $1.87) shows resilience.
• ↓U.S. revenue fell 7%, companion product sales dropped 11%.